Ann: Two-Year Results of Phase 1 SR-aGvHD Trial Presented at ISCT, page-12

First 12 Last

Share
Profile

Follow
Pledge

8,719 Posts.

1455

22/05/23

16:58

Post #: 67901647
Share

Originally posted by JB1975: ↑

Do you read CYP announcements?Usually.

Sometimes I miss details. That has happened before. This doesn't seem to be one of those times though.

I think what you are wanting me to see is - " Final start up activities underway in concert with CRO IQVIA" (CRO - I take as contract research organization)

It seems to me that you have extrapolated, (rather than that Cynata have actually said) from that piece of information, that CRO IQVIA will also be effectively managing the Australian aspects of the trial along with them managing the rest of the world as well.

On the basis of what you show here and what I've read elsewhere I am not willing to assume as you seemed to have done that CYP won't split (for the purposes of costs) the trial into an inside the US component (handled by CRO IQVIA) and an outside the US-component. I think to save money CYP might try to delegate only the US aspects of the trial to the CRO.

Expand

Yeah, right.

So who will be doing the Europe part?

You might be blowing smoke up your own backside.

Lacking resources and expertise to do trials. That's not extrapolating.

A$6 Million for the whole lot? Wowsers.

Well, CYP has entered into the 'advance stages of starting', so any moment now. It's really getting exciting now.

Super Duper close now.

Pure coincidence that the FDA P2 Trial for GVHD hasn't started before final news on MSB's FDA P3 approach?

Final advanced stages of starting in the next few weeks/months.

CYP Price at posting: 15.0¢ Sentiment: None Disclosure: Not Held
7 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

'Not possible' to port renewable gas: ACCC takes AGN to court

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

First 12 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 15.5¢		Change -0.005(3.13%)		Mkt cap ! $35.02M

Open	High	Low	Value	Volume
16.0¢	16.5¢	15.5¢	$22.43K	139.5K

Buyers (Bids)

No.	Vol.	Price($)
4	58708	15.5¢

Sellers (Offers)

Price($)	Vol.	No.
16.0¢	9763	1

View Market Depth

No.	Vol.	Price($)
4	58708	0.155
5	106673	0.150
2	45000	0.140
1	10937	0.130
1	26000	0.115

Price($)	Vol.	No.
0.160	9763	1
0.165	38474	1
0.170	70000	2
0.175	77450	2
0.180	62619	3

Last trade - 16.10pm 26/06/2025 (20 minute delay)

CYP (ASX) Chart

Ann: Two-Year Results of Phase 1 SR-aGvHD Trial Presented at ISCT, page-12

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

'Not possible' to port renewable gas: ACCC takes AGN to court

Australia’s gas crisis is here – and dying coal plants aren’t helping

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Two-Year Results of Phase 1 SR-aGvHD Trial Presented at ISCT, page-12

Top Stories

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

'Not possible' to port renewable gas: ACCC takes AGN to court

Australia’s gas crisis is here – and dying coal plants aren’t helping

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News